Featured
Malaria vaccine: 77% efficacy
EDCTP-funded phase II clinical trial in Burkina Faso demonstrates that malaria vaccine candidate R21/Matrix-M is safe, immunogenic and has an efficacy of 77%.
Tenth EDCTP Forum
The Tenth EDCTP Forum 'Equity in Research for Health' will take place from 17-21 October 2021.
Registration is now open.
EDCTP Update August 2021
EDCTP’s monthly electronic newsletter | project news, events, funding and resources
Projects
Access our online projects database and guidance information to manage EDCTP2 grants.
Achievements
See our achievements in bringing together research from Europe and Africa and developing research capacity in sub-Saharan Africa.
News
14 September 2021
African Union and EDCTP sign Memorandum of Understanding to promote new paradigm in health
11 November 2014
Home
12 August 2021
Recommendations from the EDCTP/ECRIN session on clinical trial infrastructure and capacity building in Africa
Latest Tweets
RT @VirTUAL_UoL: There is still time to register for next weeks' International Workshop on Clinical Pharmacology of HIV, Hepatitis and Othe…See the post
1 day ago
RT @DNDi: To achieve elimination and control of neglected diseases, the role of partnerships and commitment by African leaders in innovatio…See the post
1 day ago
RT @GabrielMariya: #Research & #innovation have played a vital role in fighting the #COVID19 pandemic. 💉🔬
#HERA will further incentivise R…See the post
2 days ago